JW Pharmaceutical financials at a glance

+ Portfolio

The revenue of JW Pharmaceutical is reported as 750.02309 billion Won in the fiscal year 2023. The earnings were 1529 Won per share in 2023, which was 17.17 higher than 2022. And about -5.31931 billion Won are reported as free cash flow in the financials of JW Pharmaceutical 2023. Dividends of 362.91 Won per share were paid to shareholders of JW Pharmaceutical stock KOSE:A001060 in fiscal 2023.

₩750.02B

Revenue

₩1.53k

Earnings Per Share

44.83%

Gross Margin %

₩3.05B

Free Cash Flow

Revenue

750,023.09

Earnings Per Share

1,529.00

Gross Margin %

44.83

Free Cash Flow

3,050.00

Financials

Year	Year	TTM	2023	2022	2018	2016
Rev.	Revenue	N/A	₩750.02B	₩684.35B	₩537.18B	₩0.00M
GM %	Gross Margin %	44.81%	44.83%	42.08%	36.68%	37.08%
OM	Operating Margin	12.47%	12.91%	8.84%	4.02%	5.25%
EPS	Earnings Per Share	₩1.08k	₩1.53k	₩1.30k	₩298.78	₩-,630.44
Div.	Dividends	N/A	₩362.91	₩367.65	₩239.54	₩0.00
PR %	Payout Ratio %	0	23.74%	28.17%	80.17%	0
Sha.	Shares	N/AM	23.33M	23.34M	22.46M	22.36M
OCF	Operating Cash Flow	N/A	₩21.97B	₩56.76B	₩52.11B	₩0.00M
FCF	Free Cash Flow	N/A	₩3.05B	₩46.85B	₩44.41B	₩0.00M
FCFS	Free Cash Flow Per Share	₩1.87k	₩1.01k	₩1.91k	₩1.79k	₩-,171.56

JW Pharmaceutical financials at a glance

Financials

Discover